Delivery Order SPE2DB20D2104-SPE2DB23FT84H
Award Date 6/5/23
Potential Completion Date 6/6/23
Potential Value $3.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of pharmaceutical products, specifically the medication Rexulti 1 mg tablet, to the Defense Logistics Agency (DLA). The contract, valued at $4,866.53, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order that runs until February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,788.81, is for the delivery of the antipsychotic medication Rexulti 1 mg tablets. This is a firm fixed price delivery order contract with a completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,854.64 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier to the federal government. This order is for the drug Rexulti (0.25 mg tablet, 30s) and has a completion date of May 21, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
- This federal contract award is for the delivery of Rexulti 1 mg tablets to the Defense Logistics Agency (DLA). The $4,552.35 delivery order was issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,982.92 firm fixed-price delivery order is for the supply of Rexulti 2 mg tablets. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price valued at $10,748.27 and a completion date of June 6, 2025. The contract is for the supply of Rexulti 2 mg tablets, a prescription medication. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation, indicating open...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is a delivery order valued at $11,081.84 for the supply of the pharmaceutical product Rexulti 2 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has a period of performance through March 27, 2024. This delivery order is placed under a larger indefinite delivery...
- This federal contract award is for the delivery of pharmaceutical products, primarily the medication Rexulti, to the Defense Logistics Agency (DLA) from the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,440.23 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,036,098 units of the pharmaceutical drug Rexulti (1 mg tablet, 30s). The contract has a ceiling value of $1,951.46 and a period of performance ending on November 9, 2022. This order was placed under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $6,989.87 firm fixed-price award is for the delivery of REXULTI 3 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The DLA Troop Support Medical IDC, valued at up to $999,999,999.00, serves as the primary contracting vehicle for Amerisourcebergen to...